The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients

Objectives. To examine SLEDAI-2000 cut-off scores for definition of active SLE and to determine the sensitivity to change of SLEDAI-2000 for the assessment of SLE disease activity and minimal clinically meaningful changes in score.

Bibliographic Details
Main Authors:	Yee, Chee-Seng, Farewell, Vernon T., Isenberg, David A., Griffiths, Bridget, Teh, Lee-Suan, Bruce, Ian N., Ahmad, Yasmeen, Rahman, Anisur, Prabu, Athiveeraramapandian, Akil, Mohammed, McHugh, Neil, Edwards, Christopher, D’Cruz, David, Khamashta, Munther A., Gordon, Caroline
Format:	Online
Language:	English
Published:	Oxford University Press 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077910/

id	pubmed-3077910
recordtype	oai_dc
spelling	pubmed-30779102011-04-18 The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients Yee, Chee-Seng Farewell, Vernon T. Isenberg, David A. Griffiths, Bridget Teh, Lee-Suan Bruce, Ian N. Ahmad, Yasmeen Rahman, Anisur Prabu, Athiveeraramapandian Akil, Mohammed McHugh, Neil Edwards, Christopher D’Cruz, David Khamashta, Munther A. Gordon, Caroline Clinical Science Objectives. To examine SLEDAI-2000 cut-off scores for definition of active SLE and to determine the sensitivity to change of SLEDAI-2000 for the assessment of SLE disease activity and minimal clinically meaningful changes in score. Oxford University Press 2011-05 2010-01-18 /pmc/articles/PMC3077910/ /pubmed/21245073 http://dx.doi.org/10.1093/rheumatology/keq376 Text en © The Author(s) 2011. Published by Oxford University Press on behalf of The British Society for Rheumatology. http://creativecommons.org/licenses/by-nc/2.5 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Yee, Chee-Seng Farewell, Vernon T. Isenberg, David A. Griffiths, Bridget Teh, Lee-Suan Bruce, Ian N. Ahmad, Yasmeen Rahman, Anisur Prabu, Athiveeraramapandian Akil, Mohammed McHugh, Neil Edwards, Christopher D’Cruz, David Khamashta, Munther A. Gordon, Caroline
spellingShingle	Yee, Chee-Seng Farewell, Vernon T. Isenberg, David A. Griffiths, Bridget Teh, Lee-Suan Bruce, Ian N. Ahmad, Yasmeen Rahman, Anisur Prabu, Athiveeraramapandian Akil, Mohammed McHugh, Neil Edwards, Christopher D’Cruz, David Khamashta, Munther A. Gordon, Caroline The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients
author_facet	Yee, Chee-Seng Farewell, Vernon T. Isenberg, David A. Griffiths, Bridget Teh, Lee-Suan Bruce, Ian N. Ahmad, Yasmeen Rahman, Anisur Prabu, Athiveeraramapandian Akil, Mohammed McHugh, Neil Edwards, Christopher D’Cruz, David Khamashta, Munther A. Gordon, Caroline
author_sort	Yee, Chee-Seng
title	The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients
title_short	The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients
title_full	The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients
title_fullStr	The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients
title_full_unstemmed	The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients
title_sort	use of systemic lupus erythematosus disease activity index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients
description	Objectives. To examine SLEDAI-2000 cut-off scores for definition of active SLE and to determine the sensitivity to change of SLEDAI-2000 for the assessment of SLE disease activity and minimal clinically meaningful changes in score.
publisher	Oxford University Press
publishDate	2011
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077910/
_version_	1611449507399073792

The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients

Similar Items